PageOverview.com
 

Domains targeting keyword angina treatment

Keyword angina treatment was used in the provided list of websites.

 
Number of websites/domains displayed: 14
Results found: 14
 

Similar searches:

 

Websites discovered:

Welcome to HeartSite.com
http://pageoverview.com/website-report/heartsite.com
Using multimedia, HeartSite.com was designed to educate patients and their family members about the diagnosis and treatment of heart disease. On-line lecturesare also provided
  • Expected expiration: August 27th in 2017
  • Creation date: August 28th in 1998
  • Renew date: January 8th in 2017
  • Google Analytics: 17562531-1
  • Adsense ID: pub-5298092588544248
Welcome to SpeakFromTheHeart.com
http://pageoverview.com/website-report/speakfromtheheart.com
Welcome to SpeakFromTheHeart.com. Take an active role in your angina treatment. Complete the Chronic Angina Checklist and bring it to your next cardiologist visit.
  • Expected expiration: April 27th in 2018
  • Creation date: April 27th in 2005
  • Renew date: March 31st in 2017
  • Google Analytics: 16905710-1
Cardiology, diagnosis and treatment of heart diseases
http://pageoverview.com/website-report/rjmatthewsmd.com
Cardiology is that branch of medicine which deals with the treatment of heart diseases
  • Expected expiration: June 26th in 2017
  • Creation date: June 26th in 2000
  • Renew date: June 27th in 2016
  • Google Analytics: 20634506-1
  • Adsense ID: pub-6116736350893321
The story of a remarkable and versatile medicine that is being overlooked.
http://pageoverview.com/website-report/remarkablemedicine.com
  • Expected expiration: September 21st in 2018
  • Creation date: September 21st in 1999
  • Renew date: August 23rd in 2017
34 HEART CARE | EECP Treatment in Delhi, Cure Your Angina, Cure Heart, Angioplasty, Bypass Surgery
http://pageoverview.com/website-report/34care.com
  • Expected expiration: September 16th in 2018
  • Creation date: September 16th in 2014
  • Renew date: June 24th in 2016
  • Google Analytics: 20216458-16
Neomedhospitals: Bye Bypass Surgery,Chelation Therapy,Artery Clearance Therapy-Chennai,Chelation Therapy in Chennai,Bypassing Bypass Surgery - Neomed Hospital
http://pageoverview.com/website-report/neomedhospitals.com
Neomed Hospitals in Chennai is for patients suffering from Angina,Chest pain,Coronary Artery Disease,Patients unfit for bypass, have failed bypass, do not want bypass surgery or cannot afford bypass.Dr.L.Sivabalan to Preventive Artery Clearance Therapy and Chelation Therapy.
  • Expected expiration: October 5th in 2017
  • Creation date: October 5th in 2005
  • Renew date: October 5th in 2016
  • Google Analytics: 18255947-1
Internal Medicine | Cardiology Sacramento CA
http://pageoverview.com/website-report/sacheart.com
Cardiology Sacramento CA - The Cardiologists at Sacramento Heart offer Internal Medicine and Cardiology. Our practice serves Sacramento CA and surrounding areas.
  • Expected expiration: June 16th in 2018
  • Creation date: November 20th in 1996
  • Renew date: June 16th in 2017
  • Google Analytics: 47534292-1
  • Google Plus Account: 114874620240683715264
EECP, EECP Therapy Chennai, EECP Therapy, EECP in India, Treatment for Burns in Chennai, Treatment for Diabetic Foot in Chennai, Wound Healing in Chennai, Treatment for Stroke in Chennai, Non Surgical Bypass Treatment for Heart, Chelation Therapy, Heart Bypass Surgery in Chennai, Pulsed signal therapy, Hyperbaric Oxygen Therapy Chennai, HBOT in Chennai, Laser Therapy in Chennai, Non Invasive Therapy, Angina Heart Failure Treatment, Best Cardiology Hospital in Chennai
http://pageoverview.com/website-report/oxymedhospital.in
Oxymed Hospital is limelight for its EECP treatment & therapy in South India, It is very unique and mode of action is on smaller vessels in the heart, which
  • Expected expiration: February 23rd in 2018
  • Creation date: February 23rd in 2006
  • Renew date: February 13th in 2017
  • Google Analytics: 58355359-1
  • Google Plus Account: 105351869638090207641
Inducing Remission in GPA & MPA Patients | Rituxan® GPA & MPA | HCP
http://pageoverview.com/website-report/rituxanforgpampa-hcp.com
Find information for healthcare professionals about Rituxan® (rituximab), the only FDA-approved treatment proven to induce remission in patients with GPA and MPA. INDICATION STATEMENT - Rituxan® (rituximab), in combination with glucocorticoids, is indicated for the treatment of adult patients with Granulomatosis with Polyangiitis (GPA) (Wegener’s Granulomatosis) and Microscopic Polyangiitis (MPA) - Limitations of Use: Rituxan is not recommended for use in patients with severe, active infections BOXED WARNINGS and Additional Important Safety Information BOXED WARNINGS Infusion Reactions: Rituxan administration can result in serious, including fatal, infusion reactions. Deaths within 24 hours of Rituxan infusion have occurred. Approximately 80% of fatal infusion reactions occurred in association with the first infusion. Monitor patients closely. Discontinue Rituxan infusion for severe reactions and provide medical treatment for Grade 3 or 4 infusion reactions. Severe Mucocutaneous Reactions: Severe, including fatal, mucocutaneous reactions can occur in patients receiving Rituxan. Hepatitis B Virus (HBV) Reactivation: HBV reactivation can occur in patients treated with Rituxan, in some cases resulting in fulminant hepatitis, hepatic failure, and death. Screen all patients for HBV infection before treatment initiation, and monitor patients during and after treatment with Rituxan. Discontinue Rituxan and concomitant medications in the event of HBV reactivation. Progressive Multifocal Leukoencephalopathy (PML): PML, including fatal PML, can occur in patients receiving Rituxan. Warnings and Precautions Rituxan administration can also result in additional serious, including fatal, adverse reactions including: - Tumor lysis syndrome (TLS): Administer aggressive intravenous hydration, anti‑hyperuricemic agents, monitor renal function - Infections: Withhold Rituxan and institute appropriate anti-infective therapy - Cardiac arrhythmias and angina: Discontinue infusions in case of serious or life-threatening events - Bowel obstruction and perforation: Consider and evaluate for abdominal pain, vomiting, or related symptoms - Live virus vaccines: Do not administer live virus vaccines prior to or during Rituxan - Cytopenias: Monitor blood counts at regular intervals Granulomatosis With Polyangiitis (GPA) (Wegener’s Granulomatosis) and Microscopic Polyangiitis (MPA) - Use of concomitant immunosuppressants other than corticosteroids has not been studied in GPA or MPA patients exhibiting peripheral B-cell depletion following treatment with Rituxan. Observe patients with GPA and MPA closely for signs of infection if immunosuppressants other than corticosteroids are used concomitantly - The safety and efficacy of retreatment with Rituxan have not been established in patients with GPA and MPA - Common adverse reactions (≥15%) in the clinical study were infections, nausea, diarrhea, headache, muscle spasms, anemia, and peripheral edema. Other important adverse reactions include infusion reactions You may report side effects to the FDA at (800) FDA-1088 or www.fda.gov/medwatch. You may also report side effects to Genentech at (888) 835-2555. For additional safety information, please see the Rituxan full prescribing information, including BOXED WARNINGS.
  • Expected expiration: November 27th in 2019
  • Creation date: November 27th in 2013
  • Renew date: December 1st in 2017
  • Google Analytics: 48974804-1
XtendOvite
http://pageoverview.com/website-report/heartdrop.com
Heart Drop 2000, XtendOvite Helps Maintain Cardiovascular Health and Reduce Blood Lipid levels In Adults.
  • Expected expiration: March 17th in 2021
  • Creation date: March 17th in 2000
  • Renew date: January 16th in 2018
  • Google Analytics: 20566459-1
Heart Attack | Facts | Alternatives | Prevention | Well-Being | Eine weitere WordPress-Seite
http://pageoverview.com/website-report/heartattacknew.com
Detailed answers to the most frequently asked questions concerning heart attacks. You will be able to make better decisions concerning your own treatment.
  • Expected expiration: November 24th in 2017
  • Creation date: November 24th in 2012
  • Renew date: September 9th in 2016
  • Google Analytics: 83905287-1
BRILINTA® (ticagrelor) tablets | Heart Attack Treatment
http://pageoverview.com/website-report/brilinta.com
Read about BRILINTA® (ticagrelor) tablets, a prescription medication for heart attack treatment, or severe chest pain, also known as unstable angina.
  • Expected expiration: April 21st in 2018
  • Creation date: April 21st in 2005
  • Renew date: April 17th in 2017
Alternative heart disease treatment, Best way to lower blood pressure
http://pageoverview.com/website-report/heartfit.ca
We are here to give you Alternative heart disease treatment and will tell you Best way to lower blood pressure so that it will be beneficial for your health.
  • Expected expiration: October 27th in 2018
  • Creation date: October 27th in 2006
  • Renew date: September 28th in 2017
  • Google Analytics: 67952501-1
ESMR : Bye Bye Bypass Surgery in Chennai,ESMR in chennai,Shock Wave Therapy,Shock wave therapy in cardiology
http://pageoverview.com/website-report/esmrindia.com
ESMR - A world class treatment for the first time in India, a breakthrough in management of Refractory Angina Pectoris with end-stage coronary Artery Disease not Suitable for Revascularization.Shock wave therapy in cardiology ,Shock wave therapy in cardiology in Chennai,Shock wave therapy in cardiology in india.
  • Expected expiration: August 31st in 2017
  • Creation date: August 31st in 2009
  • Renew date: September 1st in 2016
  • Google Analytics: 23797400-1
0.0203 // 2024-06-06 10:17:03
All Rights reserved 2018 © PageOverview.com